China SXT Pharmaceuticals Cash Flow Statement (2018-2025) | SXTC

Cash Flow Statement Mar2018 Sep2018 Mar2019 Sep2019 Mar2020 Sep2020 Mar2021 Sep2021 Mar2022 Sep2022 Mar2023 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025
Operating Activities
Change in Working Capital
Change in Receivables 2.60M3.89M4.18M4.57M
Change in Account Payables 2.41M2.00M1.69M1.96M1.94M1.36M1.46M1.49M1.48M1.56M1.38M1.32M1.28M1.66M1.16M0.53M
Change in Accured Expenses 0.42M0.31M0.69M0.70M
Change in Taxes 1.05M1.09M1.03M1.04M
Other Working Capital Changes 0.91M0.73M0.71M2.02M0.11M0.10M0.47M0.48M0.12M0.11M0.11M0.15M0.19M0.19M0.06M0.07M
Investing Activities
Capital Expenditures 0.63M0.57M0.65M0.18M0.33M0.45M0.36M0.36M0.36M0.34M
Financing Activities
Other financing activities 1.46M1.46M7.95M11.41M17.16M24.23M25.32M26.01M30.99M32.56M35.59M35.95M35.32M33.39M
Additional items
Free Cash Flow -0.63M-0.57M-0.65M-0.18M-0.33M-0.45M-0.36M-0.36M-0.36M-0.34M